4 results match your criteria: "Consortium at Northeastern University[Affiliation]"
Cancer Discov
January 2020
New England Inflammation and Tissue Protection Institute, a Consortium at Northeastern University, Boston, Massachusetts.
In this issue of , Fong and colleagues describe the encouraging observations of tumor regression, disease control, and survival of patients with otherwise refractory renal cell cancer with progressive disease after treatment with the conceptually novel oral antagonist of the A2A adenosine receptor (A2AR), ciforadenant. A2AR antagonists may represent the until now missing but critically important part of more effective immunotherapies of cancer, because they prevent the inhibition of tumor-reactive T and natural killer cells by blocking the immunosuppressive hypoxia-A2A-adenosinergic signaling, which represents an emerging immunosuppressive hallmark of tumors that are the most resistant to therapies..
View Article and Find Full Text PDFAnesthesiology
December 2014
From the University Hospital of the Ludwig- Maximilians-University, Department of Anesthesiology, Klinikum Grosshadern, Munich, Germany (Q.Z., A.M., I.K., A.C.); National Institute on Minority Health and Health Disparities, National Institutes of Health, Division of Intramural Research, Bethesda, Maryland (S.H.J.); National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland (A.O., D.L., J.M.W., M.S., A.C.); New England Inflammation and Tissue Protection Institute Consortium at Northeastern University, Boston, Massachusetts (A.O., D.L., M.S.); Mouse Imaging Facility, National Institute of Neurological Disorder and Stroke, National Institutes of Health, Bethesda, Maryland (B.K.); and Department of Anaesthesiology and Intensive Care, Medical Faculty of Mannheim, University of Heidelberg, Mannheim, Germany (M.T.).
Background: Liver damage by ischemia and reperfusion injury is a risk factor for morbidity and mortality after liver surgery. Postoperative oxygen treatment is routinely applied in the postanesthesia and intensive care unit after liver surgery. The risks of aggravating the injury by increasing inspiratory oxygen from 21 to 60% in the postoperative period were investigated in mice.
View Article and Find Full Text PDFBr J Pharmacol
March 2008
New England Inflammation and Tissue Protection Institute, Consortium at Northeastern University, 113 Mugar Building, 360 Huntington Avenue, Boston, MA 02115, USA.
The intensity and duration of host responses are determined by protective mechanisms that control tissue injury by dampening down inflammation. Adenosine generation and consequent effects, mediated via A2A adenosine receptors (A2AR) on effector cells, play a critical role in the pathophysiological modulation of these responses in vivo. Adenosine is both released by hypoxic cells/tissues and is also generated from extracellular nucleotides by ecto-enzymes e.
View Article and Find Full Text PDFObjective: This study was performed to determine whether hyperbaric oxygen (HBO2) therapy is protective in cecal ligation and puncture (CLP)-induced sepsis and if protection is dependent on oxygen dosing. We also wished to determine whether HBO2 affected bacterial clearance or altered macrophage production of interleukin-10 (IL-10)s in the setting of CLP sepsis. Finally, we wished to determine whether the mechanism of HBO2 protection in sepsis was dependent on IL-10 production.
View Article and Find Full Text PDF